Document 2949 DOCN M94A2949 TI Hepatobiliary disorders in HIV-patients. DT 9412 AU Verdejo J; Iniguez A; Polo R; Martinez ML; Inchaustegui L; Enriquez A; Gonzalez-Lahoz JM; Instituto de Salud Carlos III, Madrid, Spain. SO Int Conf AIDS. 1994 Aug 7-12;10(1):188 (abstract no. PB0182). Unique Identifier : AIDSLINE ICA10/94369626 AB We evaluate hepatobiliary complications and serological markers in viral hepatitis in a prospective study since February 1992. RESULTS: Patients 108 (51 AIDS-CDC 1993). Average follow-up 245 days (range 60-690). Sex: M 81/F 27. Average age 31.8 (range 21-69). Risk group: IVDU 72, Homosexual 27, Heterosexual 8, Transfusion 1. We obtained the following results: (I) Hepatobiliary complications 92 in 78 patients (78/108: 70.3%). Complications: chronic viral hepatitis 25 (19 HCV, 3 HBV, 1 HCV+HBV, 1 HBV+HDV, 1 HBV+HCV+HDV); without filiation 17; mild alterations 14 (GPT and/or GGT < 1.5 times limit of normal); infectious diseases 10 (cholangitis/chole-cystitis 6, tuberculosis 3, bacteremia 1); hepatotoxic agents 10; multiple factors 8 (HCV+Alcohol 7, HCV+hepatotoxic agents 1); alcoholism 1; acute viral hepatitis (HCV) 2; other 5 (2 angioma, 1 hepatocarcinoma, 1 cholelitiasis, 1 hydatid cyst). (II) Serological markers: 1) HBV: a) HBsAg+ 8% (HBeAg+ 50%) (Co-infection HDV 28.5%), b) HBsAg- with anti-HBc+ 72.7%, c) HCV 62.7% (we exclude the patients with EIA+ and a second-generation RIBA test indeterminate or negative). CONCLUSIONS: 1) Hepatobiliary complications are common in HIV-patients (71.5%). 2) chronic viral hepatitis HCV is the most frequent disease due to the 66.6% are IVDU. 3) In our experience, serological markers of HBV and HCV are detected in 81.1% (8% with HBsAg+) and 62.7% respectively. DE Adult Aged AIDS-Related Opportunistic Infections/COMPLICATIONS/DIAGNOSIS Biliary Tract Diseases/*COMPLICATIONS/DIAGNOSIS Female Hepatitis, Viral, Human/*COMPLICATIONS/DIAGNOSIS/TRANSMISSION Human HIV Infections/*COMPLICATIONS/DIAGNOSIS/TRANSMISSION Liver Diseases/*COMPLICATIONS/DIAGNOSIS Male Middle Age Risk Factors MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).